Rare diseases
Investigational molecules
Locations
400 Concar Drive Suite 03-101, 94402-2681, United States
Bluejay Therapeutics Inc. concentrates its clinical research on chronic hepatitis delta infection, with multiple studies assessing antiviral treatment options and treatment switching strategies in affected participants.
The sponsor's trial portfolio includes global, multicenter research across several countries, reflecting sustained attention to this severe liver infection.
Bluejay Therapeutics Inc. runs clinical trials in conditions such as Chronic hepatitis B, Hepatitis D, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
